COHERENT CORP - COHR 6 07/01/23 (IIVI) Stock Fundamental Analysis
USA - NYSE:IIVI - US19247G2066
227.08 USD
+11.82 (+5.49%)
IIVI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and the financial health of IIVI get a neutral evaluation. Nothing too spectacular is happening here. IIVI is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
IIVI had positive earnings in the past year.
IIVI had a positive operating cash flow in the past year.
IIVI had positive earnings in 4 of the past 5 years.
In the past 5 years IIVI always reported a positive cash flow from operatings.
1.2 Ratios
The profitability ratios for IIVI are negative, so there is not much use analyzing them.
IIVI has a Return On Invested Capital (1.87%) which is comparable to the rest of the industry.
IIVI had an Average Return On Invested Capital over the past 3 years of 4.47%. This is significantly below the industry average of 9.51%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 1.87% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.47%
ROIC(5y)6.09%
1.3 Margins
IIVI's Profit Margin has declined in the last couple of years.
IIVI's Operating Margin of 6.00% is fine compared to the rest of the industry. IIVI outperforms 71.32% of its industry peers.
In the last couple of years the Operating Margin of IIVI has grown nicely.
With a decent Gross Margin value of 33.06%, IIVI is doing good in the industry, outperforming 60.47% of the companies in the same industry.
IIVI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6% | ||
| PM (TTM) | N/A | ||
| GM | 33.06% |
OM growth 3Y0.85%
OM growth 5Y1.69%
PM growth 3Y-13.99%
PM growth 5Y-12.53%
GM growth 3Y-0.09%
GM growth 5Y-0.92%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IIVI is destroying value.
The number of shares outstanding for IIVI has been increased compared to 1 year ago.
Compared to 1 year ago, IIVI has a worse debt to assets ratio.
2.2 Solvency
IIVI has an Altman-Z score of 3.57. This indicates that IIVI is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.57, IIVI is doing good in the industry, outperforming 60.47% of the companies in the same industry.
IIVI has a debt to FCF ratio of 34.44. This is a negative value and a sign of low solvency as IIVI would need 34.44 years to pay back of all of its debts.
The Debt to FCF ratio of IIVI (34.44) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.58 indicates that IIVI is somewhat dependend on debt financing.
The Debt to Equity ratio of IIVI (0.58) is worse than 83.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | 34.44 | ||
| Altman-Z | 3.57 |
ROIC/WACC0.2
WACC9.56%
2.3 Liquidity
A Current Ratio of 3.08 indicates that IIVI has no problem at all paying its short term obligations.
IIVI has a Current ratio of 3.08. This is in the better half of the industry: IIVI outperforms 62.02% of its industry peers.
IIVI has a Quick Ratio of 1.82. This is a normal value and indicates that IIVI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of IIVI (1.82) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.08 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
The earnings per share for IIVI have decreased by -1.93% in the last year.
IIVI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.68% yearly.
The Revenue has grown by 49.56% in the past year. This is a very strong growth!
IIVI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.82% yearly.
EPS 1Y (TTM)-1.93%
EPS 3Y13.27%
EPS 5Y18.68%
EPS Q2Q%-38.95%
Revenue 1Y (TTM)49.56%
Revenue growth 3Y34.52%
Revenue growth 5Y27.82%
Sales Q2Q%49.84%
3.2 Future
Based on estimates for the next years, IIVI will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.68% on average per year.
IIVI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.99% yearly.
EPS Next Y2.69%
EPS Next 2Y11.05%
EPS Next 3Y15.16%
EPS Next 5Y11.68%
Revenue Next Year65.72%
Revenue Next 2Y33.82%
Revenue Next 3Y25.01%
Revenue Next 5Y17.99%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 63.97, which means the current valuation is very expensive for IIVI.
IIVI's Price/Earnings is on the same level as the industry average.
IIVI is valuated expensively when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 49.50, the valuation of IIVI can be described as expensive.
IIVI's Price/Forward Earnings is on the same level as the industry average.
IIVI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 32.68.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.97 | ||
| Fwd PE | 49.5 |
4.2 Price Multiples
IIVI's Enterprise Value to EBITDA is on the same level as the industry average.
IIVI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IIVI is cheaper than 60.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 246.31 | ||
| EV/EBITDA | 41.79 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IIVI does not grow enough to justify the current Price/Earnings ratio.
IIVI's earnings are expected to grow with 15.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)23.79
PEG (5Y)3.42
EPS Next 2Y11.05%
EPS Next 3Y15.16%
5. Dividend
5.1 Amount
No dividends for IIVI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
COHERENT CORP - COHR 6 07/01/23
NYSE:IIVI (6/30/2023, 8:21:10 PM)
227.08
+11.82 (+5.49%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners0.01%
Inst Owner Change-10.68%
Ins Owners0.76%
Ins Owner Change0%
Market Cap31.65B
Revenue(TTM)4.84B
Net Income(TTM)-162.49M
Analysts74.55
Price Target203.06 (-10.58%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-16.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.25%
Min EPS beat(2)-30.58%
Max EPS beat(2)0.07%
EPS beat(4)3
Avg EPS beat(4)-1.48%
Min EPS beat(4)-30.58%
Max EPS beat(4)22.58%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.63%
Min Revenue beat(2)-9.14%
Max Revenue beat(2)-2.12%
Revenue beat(4)1
Avg Revenue beat(4)-3.03%
Min Revenue beat(4)-9.14%
Max Revenue beat(4)1.27%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-29.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-58.41%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.97 | ||
| Fwd PE | 49.5 | ||
| P/S | 6.54 | ||
| P/FCF | 246.31 | ||
| P/OCF | 53.66 | ||
| P/B | 4.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 41.79 |
EPS(TTM)3.55
EY1.56%
EPS(NY)4.59
Fwd EY2.02%
FCF(TTM)0.92
FCFY0.41%
OCF(TTM)4.23
OCFY1.86%
SpS34.74
BVpS53.46
TBVpS-7.23
PEG (NY)23.79
PEG (5Y)3.42
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | 1.87% | ||
| ROICexc | 2.01% | ||
| ROICexgc | 6.67% | ||
| OM | 6% | ||
| PM (TTM) | N/A | ||
| GM | 33.06% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.47%
ROIC(5y)6.09%
ROICexc(3y)6.56%
ROICexc(5y)7.9%
ROICexgc(3y)12.66%
ROICexgc(5y)13.34%
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y7.05%
ROICexgc growth 5Y2.62%
ROICexc growth 3Y-2.61%
ROICexc growth 5Y-1.07%
OM growth 3Y0.85%
OM growth 5Y1.69%
PM growth 3Y-13.99%
PM growth 5Y-12.53%
GM growth 3Y-0.09%
GM growth 5Y-0.92%
F-Score3
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | 34.44 | ||
| Debt/EBITDA | 5.26 | ||
| Cap/Depr | 83.67% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.08 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 3.57 |
F-Score3
WACC9.56%
ROIC/WACC0.2
Cap/Depr(3y)75.81%
Cap/Depr(5y)113.17%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.93%
EPS 3Y13.27%
EPS 5Y18.68%
EPS Q2Q%-38.95%
EPS Next Y2.69%
EPS Next 2Y11.05%
EPS Next 3Y15.16%
EPS Next 5Y11.68%
Revenue 1Y (TTM)49.56%
Revenue growth 3Y34.52%
Revenue growth 5Y27.82%
Sales Q2Q%49.84%
Revenue Next Year65.72%
Revenue Next 2Y33.82%
Revenue Next 3Y25.01%
Revenue Next 5Y17.99%
EBIT growth 1Y-35.57%
EBIT growth 3Y35.66%
EBIT growth 5Y29.99%
EBIT Next Year120.78%
EBIT Next 3Y40.91%
EBIT Next 5Y25.33%
FCF growth 1Y-73.55%
FCF growth 3Y33.72%
FCF growth 5YN/A
OCF growth 1Y-5.44%
OCF growth 3Y32.29%
OCF growth 5Y28.36%
COHERENT CORP - COHR 6 07/01/23 / IIVI FAQ
What is the ChartMill fundamental rating of COHERENT CORP - COHR 6 07/01/23 (IIVI) stock?
ChartMill assigns a fundamental rating of 3 / 10 to IIVI.
What is the valuation status for IIVI stock?
ChartMill assigns a valuation rating of 0 / 10 to COHERENT CORP - COHR 6 07/01/23 (IIVI). This can be considered as Overvalued.
How profitable is COHERENT CORP - COHR 6 07/01/23 (IIVI) stock?
COHERENT CORP - COHR 6 07/01/23 (IIVI) has a profitability rating of 1 / 10.
Can you provide the PE and PB ratios for IIVI stock?
The Price/Earnings (PE) ratio for COHERENT CORP - COHR 6 07/01/23 (IIVI) is 63.97 and the Price/Book (PB) ratio is 4.25.
Can you provide the financial health for IIVI stock?
The financial health rating of COHERENT CORP - COHR 6 07/01/23 (IIVI) is 5 / 10.